CHROMOSOME ANALYSIS ABNORMAL side effect
What is CHROMOSOME ANALYSIS ABNORMAL ?Drugs associated with CHROMOSOME ANALYSIS ABNORMAL
GLEEVEC IMATINIB METHYLPREDNISOLO NEUPOGEN PROGRAFCHROMOSOME ANALYSIS ABNORMAL : Gleevec Side Effects Report #5541686-8
Consumer or non-health professional from JAPAN reported GLEEVEC problem on Dec 04, 2007. Female patient, 50 years of age, was diagnosed with gastrointestinal stromal tumour and was treated with GLEEVEC. After drug was administered, patient experienced the following problems/side effects: chromosome analysis abnormal, colectomy, haemorrhage, malignant neoplasm progression, small intestine operation, surgery, white blood cell count decreased, . GLEEVEC dosage: 400 MG, DAILY. Patient died on 01/01/2007.
CHROMOSOME ANALYSIS ABNORMAL : Methylprednisolo Side Effects Report #5553821-6
METHYLPREDNISOLONE problem was reported by a Consumer or non-health professional from UNITED STATES on Nov 30, 2007. Female patient, 59 years of age, was diagnosed with immunosuppression and was treated with METHYLPREDNISOLONE. After drug was administered, patient experienced the following problems/side effects: chromosome analysis abnormal, chronic myeloid leukaemia, . METHYLPREDNISOLONE dosage: unknown. During the same period patient was treated with TACROLIMUS. Patient was hospitalized. Patient recovered.
CHROMOSOME ANALYSIS ABNORMAL : Gleevec Side Effects Report #5562815-6
Consumer or non-health professional from JAPAN reported GLEEVEC problem on Dec 11, 2007. Female patient, 50 years of age, was diagnosed with gastrointestinal stromal tumour and was treated with GLEEVEC. After drug was administered, patient experienced the following problems/side effects: chromosome analysis abnormal, colectomy, haemorrhage, malignant neoplasm progression, small intestine operation, surgery, white blood cell count decreased, . GLEEVEC dosage: 400 MG, DAILY. Patient died on 01/01/2007.
CHROMOSOME ANALYSIS ABNORMAL : Imatinib Side Effects Report #5572800-6
IMATINIB problem was reported by a Health Professional from TURKEY on Dec 13, 2007. Female patient was treated with IMATINIB. After drug was administered, patient experienced the following problems/side effects: chromosome analysis abnormal, . IMATINIB dosage: unknown. Patient recovered.
CHROMOSOME ANALYSIS ABNORMAL : Gleevec Side Effects Report #5445893-4
Physician from CYPRUS reported GLEEVEC problem on Aug 31, 2007. Female patient, 24 years of age, was diagnosed with chronic myeloid leukaemia and was treated with GLEEVEC. After drug was administered, patient experienced the following problems/side effects: chromosome analysis abnormal, myelodysplastic syndrome, . GLEEVEC dosage: 400 MG / DAY. Patient recovered.
CHROMOSOME ANALYSIS ABNORMAL : Gleevec Side Effects Report #5610770-2
GLEEVEC problem was reported by a Physician from UNITED STATES on Jan 23, 2008. Male patient, 51 years of age, was diagnosed with chronic myeloid leukaemia, gout, cardiovascular event prophylaxis and was treated with GLEEVEC. After drug was administered, patient experienced the following problems/side effects: atrial fibrillation, chromosome analysis abnormal, . GLEEVEC dosage: 400 MG, QD. During the same period patient was treated with ALLOPURINOL, ASPIRIN. Patient was hospitalized. Patient recovered.
CHROMOSOME ANALYSIS ABNORMAL : Imatinib Side Effects Report #5604034-0
Health Professional from JAPAN reported IMATINIB problem on Jan 14, 2008. Male patient, 35 years of age, was diagnosed with chronic myeloid leukaemia and was treated with IMATINIB. After drug was administered, patient experienced the following problems/side effects: blast crisis in myelogenous leukaemia, chromosome analysis abnormal, disseminated intravascular coagulation, fibrin d dimer increased, fibrin degradation products, haemorrhagic diathesis, hypovolaemic shock, malignant neoplasm progression, petechiae, . IMATINIB dosage: 600 MG/D. During the same period patient was treated with DANAPAROID. Patient was hospitalized. Patient recovered.
CHROMOSOME ANALYSIS ABNORMAL : Prograf Side Effects Report #5613799-3
PROGRAF problem was reported by a Physician from UNITED STATES on Jan 21, 2008. Female patient, 54 years of age, was diagnosed with renal transplant and was treated with PROGRAF. After drug was administered, patient experienced the following problems/side effects: apathy, chromosome analysis abnormal, chronic myeloid leukaemia, depression, weight decreased, . PROGRAF dosage: unknown. During the same period patient was treated with MYCOPHENOLATE MOFETIL, METHYLPREDNISOLONE. Patient recovered.
CHROMOSOME ANALYSIS ABNORMAL : Methylprednisolo Side Effects Report #5553794-6
Consumer or non-health professional from UNITED STATES reported METHYLPREDNISOLONE problem on Nov 30, 2007. Female patient, 54 years of age, was diagnosed with immunosuppression and was treated with METHYLPREDNISOLONE. After drug was administered, patient experienced the following problems/side effects: apathy, chromosome analysis abnormal, chronic myeloid leukaemia, depression, infection, weight decreased, . METHYLPREDNISOLONE dosage: unknown. During the same period patient was treated with MYCOPHENOLATE MOFETIL, TACROLIMUS. Patient was hospitalized. Patient recovered.
CHROMOSOME ANALYSIS ABNORMAL : Methylprednisolo Side Effects Report #5553851-4
METHYLPREDNISOLONE problem was reported by a Consumer or non-health professional from UNITED STATES on Nov 30, 2007. Male patient, 55 years of age, was diagnosed with immunosuppression and was treated with METHYLPREDNISOLONE. After drug was administered, patient experienced the following problems/side effects: activities of daily living impaired, chromosome analysis abnormal, chronic myeloid leukaemia, dialysis, lethargy, lymphocyte count decreased, marrow hyperplasia, osteosclerosis, platelet count decreased, . METHYLPREDNISOLONE dosage: unknown. During the same period patient was treated with TACROLIMUS. Patient was hospitalized. Patient recovered.
CHROMOSOME ANALYSIS ABNORMAL : Gleevec Side Effects Report #5564337-5
Physician from BRAZIL reported GLEEVEC problem on Dec 10, 2007. Male patient, 40 years of age, weighting 180.8 lb, was diagnosed with myeloid leukaemia, hypertension and was treated with GLEEVEC. After drug was administered, patient experienced the following problems/side effects: amnesia, chromosome analysis abnormal, delirium, fatigue, gait disturbance, gastroenteritis rotavirus, hallucination, nausea, neutropenia, . GLEEVEC dosage: unknown. During the same period patient was treated with RENITEC, CHLORTHALIDONE, AMLODIPINE. Patient was hospitalized. Patient recovered.
CHROMOSOME ANALYSIS ABNORMAL : Gleevec Side Effects Report #5524729-7
GLEEVEC problem was reported by a Consumer or non-health professional from BRAZIL on Nov 15, 2007. Male patient, 40 years of age, weighting 180.8 lb, was diagnosed with myeloid leukaemia, hypertension and was treated with GLEEVEC. After drug was administered, patient experienced the following problems/side effects: amnesia, chromosome analysis abnormal, delirium, fatigue, gait disturbance, gastroenteritis rotavirus, hallucination, nausea, pyrexia, . GLEEVEC dosage: unknown. During the same period patient was treated with ENALAPRIL MALEATE, CHLORTHALIDONE, AMLODIPINE. Patient was hospitalized. Patient recovered.
CHROMOSOME ANALYSIS ABNORMAL : Gleevec Side Effects Report #5524946-6
Consumer or non-health professional from BRAZIL reported GLEEVEC problem on Nov 15, 2007. Male patient, 40 years of age, weighting 180.8 lb, was diagnosed with myeloid leukaemia, hypertension and was treated with GLEEVEC. After drug was administered, patient experienced the following problems/side effects: amnesia, chromosome analysis abnormal, delirium, fatigue, gait disturbance, gastroenteritis rotavirus, hallucination, nausea, pyrexia, . GLEEVEC dosage: unknown. During the same period patient was treated with ENALAPRIL MALEATE, CHLORTHALIDONE, AMLODIPINE. Patient was hospitalized. Patient recovered.
CHROMOSOME ANALYSIS ABNORMAL : Imatinib Side Effects Report #5430651-7
IMATINIB MESYLATE problem was reported by a Consumer or non-health professional from SPAIN on Aug 08, 2007. Male patient, 55 years of age, was diagnosed with chronic myeloid leukaemia and was treated with IMATINIB MESYLATE. After drug was administered, patient experienced the following problems/side effects: anaemia, chromosome analysis abnormal, erythropoiesis abnormal, myelodysplastic syndrome, neutropenia, . IMATINIB MESYLATE dosage: 400 MG/DAY. During the same period patient was treated with IMATINIB MESYLATE, INTERFERON ALFA. Patient recovered.
CHROMOSOME ANALYSIS ABNORMAL : Neupogen Side Effects Report #5430652-9
Consumer or non-health professional from SPAIN reported NEUPOGEN problem on Aug 08, 2007. Male patient, 47 years of age, was diagnosed with chronic myeloid leukaemia and was treated with NEUPOGEN. After drug was administered, patient experienced the following problems/side effects: acute myeloid leukaemia, chromosome analysis abnormal, myelodysplastic syndrome, pancytopenia, refractory anaemia with an excess of blasts, . NEUPOGEN dosage: unknown. During the same period patient was treated with IMATINIB MESYLATE. Patient died.
CHROMOSOME ANALYSIS ABNORMAL : Imatinib Side Effects Report #5391966-4
IMATINIB MESYLATE problem was reported by a Health Professional from UNITED STATES on July 13, 2007. Female patient, 42 years of age, was diagnosed with chronic myeloid leukaemia and was treated with IMATINIB MESYLATE. After drug was administered, patient experienced the following problems/side effects: acute myeloid leukaemia, chromosome analysis abnormal, complications of bone marrow transplant, . IMATINIB MESYLATE dosage: 400 MG/D. During the same period patient was treated with IMATINIB MESYLATE. Patient died.
CHROMOSOME ANALYSIS ABNORMAL : Imatinib Side Effects Report #5391966-4
Health Professional from UNITED STATES reported IMATINIB MESYLATE problem on July 13, 2007. Female patient, 42 years of age, was diagnosed with chronic myeloid leukaemia and was treated with IMATINIB MESYLATE. After drug was administered, patient experienced the following problems/side effects: acute myeloid leukaemia, chromosome analysis abnormal, complications of bone marrow transplant, . IMATINIB MESYLATE dosage: 400 MG/D. During the same period patient was treated with IMATINIB MESYLATE. Patient died.
CHROMOSOME ANALYSIS ABNORMAL : Gleevec Side Effects Report #5683961-2
GLEEVEC problem was reported by a Physician from BRAZIL on Mar 18, 2008. Male patient, 40 years of age, weighting 180.8 lb, was diagnosed with myeloid leukaemia, hypertension and was treated with GLEEVEC. After drug was administered, patient experienced the following problems/side effects: amnesia, appetite disorder, chromosome analysis abnormal, delirium, dysgeusia, fatigue, gait disturbance, gastroenteritis rotavirus, hallucination, . GLEEVEC dosage: unknown. During the same period patient was treated with RENITEC, CHLORTHALIDONE, AMLODIPINE, HYGROTON. Patient was hospitalized. Patient recovered.
CHROMOSOME ANALYSIS ABNORMAL : Gleevec Side Effects Report #5562804-1
Physician from BRAZIL reported GLEEVEC problem on Dec 07, 2007. Male patient, 65 years of age, weighting 209.4 lb, was diagnosed with chronic myeloid leukaemia and was treated with GLEEVEC. After drug was administered, patient experienced the following problems/side effects: bipolar disorder, c-reactive protein increased, chromosome analysis abnormal, gait disturbance, haemoglobin decreased, insomnia, intervertebral disc operation, intervertebral disc protrusion, nosocomial infection, . GLEEVEC dosage: 400 MG/DAY. Patient was hospitalized. Patient recovered.
CHROMOSOME ANALYSIS ABNORMAL : Gleevec Side Effects Report #5520461-4
GLEEVEC problem was reported by a Consumer or non-health professional from BRAZIL on Nov 14, 2007. Male patient, weighting 218.3 lb, was diagnosed with chronic myeloid leukaemia and was treated with GLEEVEC. After drug was administered, patient experienced the following problems/side effects: acute myeloid leukaemia, asthenia, chromosome analysis abnormal, convulsion, . GLEEVEC dosage: 400 MG/D. Patient was hospitalized. Patient recovered.
CHROMOSOME ANALYSIS ABNORMAL : Imatinib Side Effects Report #5375885-5
Health Professional from AUSTRALIA reported IMATINIB MESYLATE problem on June 27, 2007. Female patient, 56 years of age, was diagnosed with chronic myeloid leukaemia and was treated with IMATINIB MESYLATE. After drug was administered, patient experienced the following problems/side effects: acute myeloid leukaemia, bone marrow failure, chromosome analysis abnormal, chronic myeloid leukaemia, dysplasia, macrocytosis, malignant neoplasm progression, myelodysplastic syndrome, myeloid maturation arrest, . IMATINIB MESYLATE dosage: 400 MG/D. Patient died.
CHROMOSOME ANALYSIS ABNORMAL : Imatinib Side Effects Report #5375885-5
IMATINIB MESYLATE problem was reported by a Health Professional from AUSTRALIA on June 27, 2007. Female patient, 56 years of age, was diagnosed with chronic myeloid leukaemia and was treated with IMATINIB MESYLATE. After drug was administered, patient experienced the following problems/side effects: acute myeloid leukaemia, bone marrow failure, chromosome analysis abnormal, chronic myeloid leukaemia, dysplasia, macrocytosis, malignant neoplasm progression, myelodysplastic syndrome, myeloid maturation arrest, . IMATINIB MESYLATE dosage: 400 MG/D. Patient died.